Sanford Burnham Prebys researchers awarded $6.4M to advance treatment for substance use disorders

Sanford Burnham Prebys Professor Nicholas Cosford, Ph.D., has been awarded $6.4M from the National Institute on Drug Abuse (NIDA) to test new potential drugs to treat opioid and methamphetamine use disorders. The three-year project will be completed with partners from Wake Forest University School of Medicine and Camino Pharma, LLC.

Study Finds Improvement for Those Receiving Medication for Opioid Use Disorder With Contingency Management Used

A systematic review and meta-analysis found that using contingency management (CM) at end-of-treatment improved outcomes on six common clinical problems during medication for OUD (MOUD): psychomotor stimulant use, polysubstance use, illicit-opioid use, cigarette smoking, therapy attendance, and medication adherence.